Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
8.58
+0.13 (1.54%)
At close: Mar 6, 2026
HKG:3613 Market Cap
HKG:3613 has a market cap or net worth of 7.18 billion as of March 6, 2026. Its market cap has increased by 5.28% in one year.
Market Cap
7.18B
Enterprise Value
5.50B
Revenue
1.71B
Ranking
n/a
PE Ratio
13.94
Stock Price
8.58
Market Cap Chart
Since May 7, 2013, HKG:3613's market cap has increased from 5.22B to 7.18B, an increase of 37.49%. That is a compound annual growth rate of 2.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.18B | 1.42% |
| Dec 31, 2025 | 7.08B | -3.64% |
| Dec 31, 2024 | 7.35B | -27.68% |
| Dec 29, 2023 | 10.16B | 5.93% |
| Dec 30, 2022 | 9.59B | -14.61% |
| Dec 31, 2021 | 11.23B | 64.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 14.30B |
| CanSino Biologics | 13.24B |
| Sihuan Pharmaceutical Holdings Group | 12.62B |
| Shandong Xinhua Pharmaceutical Company | 9.92B |
| Luye Pharma Group | 9.79B |
| China Traditional Chinese Medicine Holdings Co. | 9.67B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.48B |
| SSY Group | 6.84B |